News
Cancer Center Awards Mini-Grants in Support of Diversity, Professional Development
The Cancer Center’s Office of Diversity, Equity, Inclusion, and Accessibility (DEIA) recently awarded 20 mini-grants to support career development activities for faculty, staff, and trainees across the UCSF cancer community. Made available to women, minorities, and persons with disabilities –
UCSF and UCLA to Host Inaugural PSMA PET Conference in January 2024
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in-person in San Francisco on January 18-19, 2024. The event is co-sponsored by UC San Francisco and
Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?
Doctors often prescribe radiation along with surgery to treat a brain tumor called meningioma that originates in the protective membranes surrounding the brain. But side effects from radiation can be serious, including memory loss and cognitive decline, so it’s important to know which patients
Wiita Team Identifies a Novel Target for Acute Myeloid Leukemia
While immunotherapy has been successful for a number of aggressive cancers, acute myeloid leukemia (AML), a hematologic malignancy with dismal outcomes, has no currently known immunotherapy targets. In a recently published study in Nature Cancer, Arun Wiita, MD, PhD reports the hurdles and successes
UCSF Health Hospitals Earn ‘A’ in Patient Safety
UCSF Health hospitals at Mission Bay, Parnassus Heights and Mount Zion have earned an “A” Hospital Safety Grade from the health care transparency nonprofit, The Leapfrog Group. Fewer than 1 in 3 hospitals nationwide can say the same. The Leapfrog Hospital Safety Grade assigns letter grades to
Leading a Paradigm Shift in Cancer Research
When Associate Professor of Otolaryngology Matthew Spitzer, PhD, was in fifth grade, his mom was diagnosed with breast cancer. She passed away while he was in college. “That was a strong motivating force for me to get involved in cancer research,” Dr. Spitzer said. Shortly thereafter, Dr. Spitzer
Brain Tumor SPORE grant at UCSF Receives $12 Million Renewal from NCI
With a renewed Specialized Program of Research Excellence (SPORE) grant, the UC San Francisco Brain Tumor Center is receiving $12 million dollars over five years to translate scientific findings into improved care for people with brain tumors. The award marks the fifth cycle of continuous support